Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
about
A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic painDiabetic neuropathic pain: Physiopathology and treatmentPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisEnigma of painful diabetic neuropathy: can we use the basic science, research outcomes and real-world data to help improve patient care and outcomes?Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Treatment of painful diabetic neuropathyBurning through the pain: treatments for diabetic neuropathy.Mechanisms and management of diabetic painful distal symmetrical polyneuropathy.Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.Lost but making progress--Where will new analgesic drugs come from?A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain.Pharmacological treatment of diabetic peripheral neuropathy.The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system.Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment ScaleIs duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trialsVitamin D for the treatment of painful diabetic neuropathy.Neurologic complications of diabetes.Diagnosis and management of neuropathic pain.Drug combinations in the treatment of neuropathic pain.Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.Topical analgesics for neuropathic pain in the elderly: current and future prospects.Understanding and treating painful diabetic neuropathy: time for a paradigm shift.Amitriptyline for the treatment of fibromyalgia: a comprehensive review.Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.A Systematic Review of Treatment of Painful Diabetic Neuropathy by Pain Phenotype versus Treatment Based on Medical Comorbidities.Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe - the role of the lidocaine 5% medicated plaster.Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.Oral pregabalin for postoperative pain relief after third molar extraction: a randomized controlled clinical trial.Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?Pregabalin for the treatment of neuropathic pain: a narrative review for primary care providers.Effect of pregabalin on contextual memory deficits and inflammatory state-related protein expression in streptozotocin-induced diabetic mice.Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetineCombination treatment of neuropathic pain: Danish expert recommendations based on a Delphi process.Pregabalin alters nociceptive behavior and expression level of P2X3 receptor in the spinal dorsal horn in a rat model induced by chronic compression of the dorsal root ganglion.Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement.Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain.Clinical Phenotype of Diabetic Peripheral Neuropathy and Relation to Symptom Patterns: Cluster and Factor Analysis in Patients with Type 2 Diabetes in Korea.Ultra-Low Doses of Naltrexone Enhance the Antiallodynic Effect of Pregabalin or Gabapentin in Neuropathic Rats.Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin
P2860
Q26797234-BE1CCFED-F0E8-41F2-BBF8-084D58601502Q27004604-4FEDFDD4-C55E-49C3-970D-84DBCF3F110DQ28085455-9BF26558-5237-41B5-B228-8FCD3EE27DBCQ31043237-C15546AF-C2E7-4965-A4FE-7075E8219CE4Q33583006-BABA9CD0-4477-4CB5-8F99-B4D065BE34ABQ34456265-6A883C50-2BA2-4660-9A21-8DEA9474779DQ34485306-EAA03041-2FDC-4478-88F1-BA2325156BBAQ34655586-C4F5D5D7-6F87-4F94-ACE4-42C66259BD58Q34756198-BFAB6272-656F-4088-99FD-CD2C36CD2C13Q35058471-0B5333F9-C40D-4C2B-8787-D5A2FB109926Q35061149-BF39DAD1-EEE9-47D1-8228-3672AB79D89FQ35669997-64F467DB-EB95-4455-AFC7-F7A7DE2B6537Q35974778-3805E32C-DA80-41C0-AC64-BA31C95B3486Q36117942-0DDAF7E6-3CB4-4881-9662-F24D88982A2EQ36574971-0352B394-E4F9-4DD9-BB77-FD1F512578A1Q36707172-70D35933-6049-463F-9BB6-169716E0E25CQ38210942-A833E65C-7A51-478E-83E7-270C0AAB4B6BQ38222253-842B707E-55F9-4555-BCE7-2F0C190E0862Q38258294-E8CC6C73-9801-4B26-AACD-04F28928C86AQ38264622-4661FFE5-6035-4FAE-8B44-8A48A451E7E9Q38265422-0C010C8B-8704-4D45-AF37-F497981119D6Q38394422-85B476F2-8AC1-4C6F-A08C-AF41B05B4183Q38591298-C6F81DBC-B784-4BC4-9191-F8FA93340A0EQ38603148-B5D82815-7566-4979-92E7-9E970C24EA6AQ38662818-D652E197-D2CA-4100-974B-621D852A0C5EQ38767631-FD4940EA-FC04-4057-BD0A-0D37D26DA25AQ38798588-68DBD3CD-5E99-45F4-BD2F-D6BCF520FA40Q39180635-D4F8AC07-EF3F-4DCE-84E5-40AB356F8D0AQ39184267-EF57DD7C-3B91-44C5-B5A0-F2F4AE084289Q39252064-5A012581-8EE2-4343-B0C0-2A659E42AFFDQ41568885-902A7374-1F80-4141-BC52-9C7C936CCAA0Q42283214-AD887CA9-2AA5-42A7-AFF4-84FEEA61037AQ42331651-F461B0F1-19FC-4D8A-9258-F0CA8B357DA4Q42708860-A541AE41-116B-43D1-81DD-C6999253C36FQ47161733-56A25A0F-2953-4DFC-A77A-ACB52A046E65Q47598680-8DAC2CD7-13CD-41AF-AEC3-9A3CBA564C6FQ47638581-7EB3C101-E22E-449A-B6AF-94414F097120Q48134405-F840F560-9BF1-48C9-8421-43B0ECC361FDQ52887626-6DA616C6-C23D-4F68-9653-FA9B48E8351AQ57111430-8F932A5D-B37C-479F-ADC0-EA7E6CB99AC3
P2860
Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Duloxetine and pregabalin: hig ...... c peripheral neuropathic pain.
@en
Duloxetine and pregabalin: hig ...... c peripheral neuropathic pain.
@nl
type
label
Duloxetine and pregabalin: hig ...... c peripheral neuropathic pain.
@en
Duloxetine and pregabalin: hig ...... c peripheral neuropathic pain.
@nl
prefLabel
Duloxetine and pregabalin: hig ...... c peripheral neuropathic pain.
@en
Duloxetine and pregabalin: hig ...... c peripheral neuropathic pain.
@nl
P2093
P1433
P1476
Duloxetine and pregabalin: hig ...... c peripheral neuropathic pain.
@en
P2093
Alberto Lledo
Alexander Schacht
Didier Bouhassira
Giorgio Cruccu
Stefan Wilhelm
Thomas Tölle
Vladimir Skljarevski
P304
P356
10.1016/J.PAIN.2013.05.043
P407
P577
2013-05-31T00:00:00Z